Hint mode is switched on Switch off

Zenas Biopharma, ordinary share
ZBIO, US98937L1052

Add a stock to WL
Choose all Reset all
Zenas Biopharma, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Zenas Biopharma, Inc. operates as a biopharmaceutical company. The Company focuses on development and commercialization of immunology-based therapies for multiple autoimmune diseases. Zenas Biopharma serves patients and healthcare professionals worldwide.
  • Issuer
  • Full borrower / issuer name
    Zenas Biopharma Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    ZBIO
  • Placement
    13.09.2024
  • Lock up period
    180
  • Number of papers
    13,235,294
  • Volume of raised funds
    225 mln USD
  • Placement share
    33.26%
  • Final placement price
    17 USD
  • Price change since placement date
    84.15%
  • By capitalization
    676.47 mln USD

IFRS/US GAAP reports

2025
I q eng
2024
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

11/05/2026 Zenas Biopharma: Results Of Operations And Financial Condition, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Submission Of Matters To A Vote Of Security Holders, Financial Statements And Exhibits
26/03/2026 Zenas Biopharma: Entry Into A Material Definitive Agreement, Creation Of A Direct Financial Obligation Or An Offbalance Sheet Arrangement, Other Events, Financial Statements And Exhibits
05/01/2026 Zenas Biopharma: Results Of Operations And Financial Condition, Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
22/12/2025 Zenas BioPharma, Inc. (NASDAQ: ZBIO) Maintains "Buy" Rating and Grants Stock Options
10/12/2025 Zenas Biopharma: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
All organization news

Domestic and international bonds of the issuer

Holders

Industry Leaders

Registration is required to get access.